Evidence map›Paper›PMID 35232849›Full record

ArticlePostgraduate medical journal2022

Prevalence of COVID-19 in patients with rheumatoid arthritis (RA) already treated with hydroxychloroquine (HCQ) compared with HCQ-naive patients with RA: a multicentre cross-sectional study.

Maryam Khoubnasabjafari, Abolghasem Jouyban, Aida Malek Mahdavi, Leila Namvar, Kamal Esalatmanesh, Mehrzad Hajialilo, Saeed Dastgiri, Mohsen Soroush, Saeid Safiri, Alireza Khabbazi

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Postgraduate medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Maryam KhoubnasabjafariTuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran.
Abolghasem JouybanPharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran.
Aida Malek MahdaviConnective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran.
Leila NamvarTuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran.
Kamal EsalatmaneshAutoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Mehrzad HajialiloConnective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran.
Saeed DastgiriTabriz Health Services Management Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran.
Mohsen SoroushRheumatology Section, Department of Internal Medicine, AJA University of Medical Sciences, Tehran, Tehran, Iran.
Saeid SafiriPhysical Medicine and Rehabilitation Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran.
Alireza KhabbaziConnective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran dr_khabbazi@yahoo.com.ORCID 0000-0002-9482-6967

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antirheumatic AgentsArthritis, RheumatoidCOVID-19 Drug TreatmentCross-Sectional StudiesHumansHydroxychloroquinePrevalenceSARS-CoV-2Antirheumatic AgentsHydroxychloroquineCOVID-19rheumatology

Identifiers

PMID35232849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.